PAK1IP1
p21-activated protein kinase-interacting protein 1
Also known as: bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, PK1IP_HUMAN, WDR84
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NWT1
- Gene
- PAK1IP1
- Ensembl
- ENSG00000111845
- Chromosome
- 6
- Canonical length
- 392 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoli
OverviewNCBI Gene
Predicted to enable protein kinase inhibitor activity. Involved in regulation of signal transduction by p53 class mediator and ribosomal large subunit biogenesis. Located in nucleolus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
392 residues, UniProt reviewed canonical sequence.
>Q9NWT1|PAK1IP1
1 MELVAGCYEQ VLFGFAVHPE PEACGDHEQW TLVADFTHHA HTASLSAVAV NSRFVVTGSK
61 DETIHIYDMK KKIEHGALVH HSGTITCLKF YGNRHLISGA EDGLICIWDA KKWECLKSIK
121 AHKGQVTFLS IHPSGKLALS VGTDKTLRTW NLVEGRSAFI KNIKQNAHIV EWSPRGEQYV
181 VIIQNKIDIY QLDTASISGT ITNEKRISSV KFLSESVLAV AGDEEVIRFF DCDSLVCLCE
241 FKAHENRVKD MFSFEIPEHH VIVSASSDGF IKMWKLKQDK KVPPSLLCEI NTNARLTCLG
301 VWLDKVADMK ESLPPAAEPS PVSKEQSKIG KKEPGDTVHK EEKRSKPNTK KRGLTGDSKK
361 ATKESGLIST KKRKMVEMLE KKRKKKKIKT MQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PAK1IP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 39 nTPM
Expression across tissuesHPA
Tissue
- prostate: 39 nTPM
- esophagus: 19 nTPM
- skeletal muscle: 17 nTPM
- adipose tissue: 15 nTPM
- liver: 13 nTPM
- endometrium: 12 nTPM
Single-cell type
- erythrocyte progenitors: 50 nCPM
- basal keratinocytes: 35 nCPM
- esophageal basal cells: 34 nCPM
- differentiating spermatogonia: 33 nCPM
- suprabasal keratinocytes: 32 nCPM
- gastric progenitor cells: 31 nCPM
Immune cell
- plasmacytoid DC: 14 nTPM
- naive CD8 T-cell: 14 nTPM
- intermediate monocyte: 12 nTPM
- myeloid DC: 12 nTPM
- naive CD4 T-cell: 11 nTPM
- non-classical monocyte: 10 nTPM
Brain region
- white matter: 8.2 nTPM
- hypothalamus: 6.8 nTPM
- cerebral cortex: 6.7 nTPM
- midbrain: 6.7 nTPM
- medulla oblongata: 6.4 nTPM
- pons: 6.3 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.52
- gnomAD pLI
- 0.36
- gnomAD missense Z
- 0.83
- DepMap mean gene effect
- -1.29
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell population proliferation
- maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
- negative regulation of signal transduction
- regulation of signal transduction by p53 class mediator
- ribosomal large subunit biogenesis
- roof of mouth development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PAK1IP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PAK1IP1 as an antibody target. Whether an autoantibody or antibody against PAK1IP1 could matter depends on whether native PAK1IP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PAK1IP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PAK1IP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...